Transfusion Medicine

Papers
(The TQCC of Transfusion Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
2021: That was the year that was16
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda16
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage15
Author Index15
Issue Information12
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion10
Drivers of blood use in paediatric trauma: A retrospective cohort study10
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major10
10
Hemolysis during therapeutic plasma exchange: A rare phenomena9
Cold agglutinin syndrome in a patient with anaemia and beta‐thalassemia trait9
Reflection from managing blood supply during social unrest9
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis8
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach8
Lipidomic changes occurring in platelets during extended cold storage7
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene7
A possible dose‐response equation: Viral load after plasma infusion in COVID‐19 patients and anti‐SARS‐CoV‐2 antibody titers in convalescent plasma7
SHOT UK Collaborative Reviewing and Reforming IT Processes in Transfusion (SCRIPT) survey: Laboratory information management systems: Are we ready for digital transformation?7
Issue Information7
Plenary session III7
Issue Information7
A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding7
6
CEBPA and GATA2 mutation and a transient blood group discrepancy in a patient with acute myeloid leukaemia6
The need for and challenges of comparing SARS‐CoV‐2 antibody assays6
Placebo and nocebo effects in transfusion medicine6
Improved detection of hepatitis C virus‐positive blood donors and determination of infection status5
Plenary II5
Issue Information5
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) stream of the BLOOD 2022 Meeting 11th – 14th September 2022, Sydney, Australia5
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia5
5
Deviations in red cell blood component temperature during laboratory processing and at blood return monitored by a time–temperature indicator device5
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients5
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study5
Identification of two novel RHD and one novel RHCE gene promoter variants in Chinese Han blood donors5
Pitfalls of reasoning in hospital‐based transfusion medicine5
Issue Information4
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient4
Chikungunya and Mayaro infective viruses in components of blood4
4
Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy4
D−− phenotype in a South Indian family: A multicentric approach to workup and management4
Poster Presentations4
Author index4
Serological and molecular characterisation of the most prevalent weak D variants in Croatian population4
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion3
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia3
Issue Information3
The contribution and potential of older blood donors in Asia Pacific regions3
Prevalence of anaemia among blood donors in eastern Morocco: The need for pre‐donation haemoglobin assessment3
Lessons learned from the CONCOR‐1 trial3
3
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood3
3
Acute pancreatitis from a delayed haemolytic transfusion reaction3
An assessment of the management of anaemia in acute care settings in the United Kingdom: The value of a collaborative approach3
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic3
Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation3
3
Primary or anamnestic antibody response to the D antigen (RhD)after bone grafting: Case report and implications3
Role of ABO blood system in COVID‐19: Findings from a southern Italian study3
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors2
SARS‐CoV‐2 infection in the blood transfusion setting2
Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–20152
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio2
Evidence Cornered: Transfusion Evidence Summary – Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)2
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐22
An accurate genetic assay to identify human neutrophil antigen 2 deficiency2
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection2
Safe handovers: Safe patients‐why good quality structured handovers in the transfusion laboratory are important2
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease2
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada2
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’2
2
High B‐cell activating factor levels in multi‐transfused thalassemia patients2
BGvar: A comprehensive resource for blood group immunogenetics2
Issue Information2
Understanding hepcidin for iron management in pregnancy2
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England2
Severe fetal anaemia due to red cell alloimmunisation in a Rhnull woman: A case report2
Issue Information2
Plenary session I2
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression2
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study2
Red blood cell transfusion in myelodysplastic syndromes: A systematic review2
A review of immunoglobulin use in a district general hospital setting2
Fresh frozen plasma: Beyond coagulation factor content2
Machine learning for predicting preoperative red blood cell demand2
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures1
Wednesday 18 September 2024 Simultaneous sessions1
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review1
Evidence cornered: Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT trial)1
Does decreasing the incubation period used in the antibody screen affect its sensitivity?1
SARS‐CoV‐2‐associated warm autoimmune haemolytic anaemia in an immunosuppressed patient: The trend continues1
Recurrent pregnancy loss in a patient with anti‐Rh171
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants1
Issue Information1
Issue Information1
Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors1
A second look at the mortality in thrombotic thrombocytopenic purpura score: An external validation study1
Notes from the Basho of the blood service1
Plenary III1
On consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities1
Critical appraisal of knowledge, attitude and practice studies for blood donation in India1
Plenary I1
The effect of non‐point‐of‐care haemostasis management protocol implementation in cardiac surgery: A systematic review1
Thursday 15th September 2022 Simultaneous sessions1
Issue Information1
Guideline for the investigation and management of red cell antibodies in pregnancy: A British Society for Haematology guideline1
1
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia1
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review1
Issue Information1
What is best practice for the prevention of anti‐D alloimmunisation in D‐negative recipients receiving solid organ transplants from D‐positive donors1
Poster session1
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) Stream of the BLOOD 2023 Meeting 5th – 8th November 2023, Melbourne, Australia1
Evaluation of platelet concentrates prepared using different methods after overnight holding (18–24 h) of whole blood at room temperature1
Blood transfusion needs in COVID‐19 patients: An observational prospective unicentric study1
Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo1
1
Issue Information1
Knowledge and attitudes of apheresis donors regarding apheresis blood donation1
Anti‐AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia1
Cost analysis of care and blood transfusions in patients with Major Obstetric Haemorrhage in Ireland1
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature1
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation1
Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso1
Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the United Kingdom1
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP1
Plenary session III1
Validation of the Sysmex XN analyser and Blood Bank mode for the quality and safety of donor blood and transfusion products1
Double or nothing: Costs of duplicate haematinic ordering in medical inpatients1
Preventing misinterpretation of rare blood types in clinical laboratories: A case study on B3 phenotype1
1
Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis1
UK national survey of anticoagulation in extra‐corporeal photopheresis—Is it time for a UK consensus statement?1
Plasma exchange in acute hemolytic reaction due to ABO‐incompatible erythrocyte concentrate transfusions: Single center experience1
Oral Abstracts1
Evaluation of two temperature storage conditions for full blood count samples from Lifeblood's donors1
Issue Information1
Assessing motivations for non‐living and living organ donation among individuals with and without a history of blood donation1
A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour1
Suggested blood donor deferral strategy regarding hepatitis B infections in China1
Extended red blood cell matching for all transfusion recipients is feasible1
E‐learning/online education in transfusion medicine: A cross‐sectional international survey1
Universal new blood cell elution method with extensive phenotyping1
A challenge for blood management: A patient presenting anti‐Vel antibody undergoing orthotopic liver transplantation1
0.12693095207214